| UNITED STATES | OMB APPROVAL | ||
| SECURITIES AND EXCHANGE COMMISSION | OMB Number: | 3235 -0167 | |
| Washington, D.C. 20549 | Expires: | August 31, 2027 | |
| FORM 15 | Estimated average burden hours per response | 1.50 |
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
| Commission File Number | 000-55450 |
| Medicine Man Technologies, Inc |
| (Exact name of registrant as specified in its charter) |
| 865 Albion St., Suite 300, Denver, CO 80220 |
| (Address, including zip code, and telephone number, including area code, of registrant s principal executive offices) |
| Common Stock, $0.001 Par Value Per Share |
| (Title of each class of securities covered by this Form) |
| NONE |
| (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) |
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | x | |
| Rule 12g-4(a)(2) | ¨ | |
| Rule 12h-3(b)(1)(i) | ¨ | |
| Rule 12h-3(b)(1)(ii) | ¨ | |
| Rule l5d-6 | x | |
| Rule 15d-22(b) | ¨ |
| Approximate number of holders of record as of the certification or notice date: | 213 |
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: | 11-17-2025 | By: | /s/ Christine Jones | |
| Christine Jones, Chief Legal Officer | ||||
| SEC 2069 (08-11) | Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number. |
| Board of Governors of the Federal Reserve System | OMB Number 7100-0091 | Approval expires February 28, 2026 |